Results 261 to 270 of about 53,193 (289)

Responses of the Normal Human to Infusions of Plasma from Patients with Graves\u27 Disease [PDF]

, 1965
Arnaud, Claude D., Engbring, Norman H., Kneubuhler, Hans A., Seiling, Virginia L., Wightman, Bruce K.   +4 more
core   +1 more source

[Case Report: Histological Transformation to Atypical Carcinoid in RET Fusion-positive NSCLC Following Immune Therapy Resistance]. [PDF]

Zhongguo Fei Ai Za Zhi
Zhang Y, Zhang H, Zhong W, Chen M, Wang M.   +4 more
europepmc   +1 more source

Concurrent KRAS p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer: a case report. [PDF]

Diagn Pathol
Bedau T, Heydt C, Siebolts U, Zander T, Kraemer M, Loeser H, Buettner R, Quaas A.   +7 more
europepmc   +1 more source

Selpercatinib in RET Fusion–Positive Non–Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial

Oliver Gautschi, Keunchil Park, Benjamin Solomon, Pascale Tomasini, Herbert H. Loong, Filippo de Braud, Kōichi Goto, Patrick Peterson, Scott Barker, Katherine Liming, Geoffrey R. Oxnard, Bente Frimodt‐Moller, Alexander Drilon   +12 more
openalex   +2 more sources

Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial. [PDF]

Signal Transduct Target Ther
Ruan DY, Huang WW, Li Y, Zhao Y, Shi Y, Jia Y, Cang S, Zhang W, Shi J, Chen J, Lin J, Liu Y, Xu J, Ouyang W, Fang J, Zhuang W, Liu C, Bu Q, Li M, Meng X, Sun M, Yang N, Dong X, Pan Y, Li X, Qu X, Zhang T, Yuan X, Hu S, Guo W, Li Y, Li S, Liu D, Song F, Tan L, Yu Y, Yu X, Zang A, Sun C, Zhang Q, Zou K, Dan M, Xu RH, Zhao H.   +43 more
europepmc   +1 more source

Activation of the AKT-mTOR pathway confers selpercatinib resistance in thyroid cancer cells harboring the <i>CCDC6-RET</i> fusion gene. [PDF]

Biochem Biophys Rep
Amitani M, Shimizu T, Oba T, Kawamura M, Ito KI.   +4 more
europepmc   +1 more source

Efficacy of immunotherapy in RET fusion-positive NSCLC: A meta-analysis. [PDF]

Heliyon
Peng Z, Ding K, Xie M, Xu Y.
europepmc   +1 more source

Matching-adjusted indirect comparison of selpercatinib and pralsetinib in <i>RET</i> fusion-positive non-small cell lung cancer. [PDF]

Future Oncol
Hochmair M, Kiiskinen U, D'yachkova Y, Puri T, Wang X, Wolowacz S, Vickers A, Nadal E.   +7 more
europepmc   +1 more source

BAM files for "Standardized molecular detection of RET and other gene fusions in Thyroid Cancer: A two-site validation study"

Marta Sesé
openalex   +1 more source